Shares of ServiceNow, Inc. (NOW) have traded between $N/A. The next earnings date is set for Jan 29, 2020. Let’s see how its prospects are shaping up.
What does ServiceNow, Inc.(NOW) do?
ServiceNow, Inc. engages in the provision of enterprise cloud computing solutions. It offers customer and facilities service management, orchestration core, service mapping, cloud and portfolio management, edge encryption, performance analytics, service portal designer, visual task boards and configuration management database. The firm offers its solutions for the industries under the categories of Healthcare, Education, Government and Financial services. The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.
NOW Insider Trading Insight
On 2020-01-13, Desai Chirantan Jitendra Chief Product Officer sold 1,563 shares of NOW. That represents a value of $37,134. Not to be outdone, on 2020-01-13, Luddy Frederic B S – Sale sold22,000 shares of NOW. These insiders are clearly in the know because they work closely with the company.
The RLMD Consensus Price Target
The mean recommendation of Relmada Therapeutics, Inc. from top Wall Street analysts is a Moderate Buy. That is based on 2 analysts who work on the Street. Based on 2 analysts offering 12 month price targets for Relmada Therapeutics in the last 3 months. The average price target is $57.00 with a high forecast of $64.00 and a low forecast of $50.00. The average price target represents a 31.64% increase from the last price of $43.30.
RLMD Intraday Trading
RLMD is due to report earnings on Feb 12, 2020. In the last year the price has ranged from 4.6 – 48. Recently, Kelly Paul Edward purchased 5,000 shares of RLMD. He is a $22,494 shareholder in RLMD.
Looking for stocks similar to NOW and RLMD?